Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Transcriptomic and pathological profiling of a new congenic mouse model with Lepr mutation: Evaluating susceptibility to the development of obesity and NAFLD

Autor: MJ Mahesh Kumar, Shailendra Arindkar, Masum Saini, Perumal Nagarajan

Publikováno v: Genes and Diseases, Vol 11, Iss 3, Pp 100982- (2024)

Externí odkaz: https://doaj.org/article/2d1ea074c5254471a3ce55ad5e46f97a

Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice

Autor: Yoshitomo Hamano, Fuyu Ito, Osamu Suzuki, Minako Koura, Shuji Matsuoka, Toshiyuki Kobayashi, Yoshinobu Sugitani, Nadila Wali, Ai Koyanagi, Okio Hino, Shoichi Suzuki, Ryuichi Sugamata, Hiromichi Yoshizawa, Wako Yumura, Naoki Maruyama, Yosuke Kameoka, Yoshihiro Noda, Yasuko Hasegawa, Tomio Arai, Kazuo Suzuki

Publikováno v: Autoimmunity, Vol 52, Iss 5-6, Pp 208-219 (2019)

Lupus nephritis (LN) is the secondary glomerulonephritis (GN) involved in systemic lupus erythematosus (SLE) and a typical immune complex-type GN. Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) is an autoimmune disease cha

Externí odkaz: https://doaj.org/article/c5f3a97726434216bf49c6f8ddfda190

Transcriptomic and pathological profiling of a new congenic mouse model with Lepr mutation: Evaluating susceptibility to the development of obesity and NAFLD.

Autor: Kumar MM; Center for Cellular and Molecular Biology, Hyderabad 500007, India., Arindkar S; National Institute of Immunology, New Delhi 100067, India., Saini M; Regional Center for Biotechnology, Faridabad 121001, India., Nagarajan P; National Institute of Immunology, New Delhi 100067, India.

Publikováno v: Genes & diseases [Genes Dis] 2023 Jun 21; Vol. 11 (3), pp. 100982. Date of Electronic Publication: 2023 Jun 21 (Print Publication: 2024).